Anti Tissue Transglutaminase IgA (TTG) at Ayzal Lab

Book at Ayzal Lab · Lahore

Book this test

Ayzal Lab logo

Ayzal Lab

30% off
Rs. 1,540Rs. 2,200

Anti Tissue Transglutaminase IgA (TTG) at Ayzal Lab

The Anti Tissue Transglutaminase IgA (tTG-IgA) test is a highly sensitive and specific blood test used primarily as the first-line screening tool for celiac disease. Celiac disease is a serious autoimmune disorder triggered by the ingestion of gluten—a protein found in wheat, barley, and rye. In individuals with celiac disease, the immune system mistakenly identifies gluten as a threat and produces autoantibodies, specifically targeting the tissue transglutaminase enzyme located in the small intestinal lining. Ayzal Lab, located in Lahore, Pakistan, offers this specialized serological assay to assist clinicians in accurately diagnosing gluten-sensitive enteropathy and monitoring patient adherence to a gluten-free diet.

The tissue transglutaminase enzyme plays a crucial role in the structural integrity of the extracellular matrix within the gastrointestinal tract. When gluten is consumed, it is broken down into gliadin peptides. In genetically susceptible individuals, these peptides are deamidated by tTG, creating a highly immunogenic compound that triggers an inflammatory cascade. This autoimmune response leads to progressive damage of the small intestinal mucosa, characterized by villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis. By measuring the concentration of IgA antibodies directed against tTG in the blood, the medical team at Ayzal Lab can provide vital diagnostic data that helps distinguish celiac disease from other malabsorptive or inflammatory bowel conditions.

Understanding the clinical value of this test is essential for patients experiencing chronic gastrointestinal distress or systemic symptoms of malabsorption. The tTG-IgA test boasts a sensitivity and specificity of over 95% in individuals who continue to consume a gluten-containing diet. This makes it an invaluable, minimally invasive alternative to immediate duodenal biopsy, although a biopsy remains the gold standard for confirming a definitive diagnosis. By utilizing advanced chemiluminescent immunoassay (CLIA) or enzyme-linked immunosorbent assay (ELISA) technologies, Ayzal Lab ensures that patients receive highly precise, reproducible, and clinically actionable results to guide their healthcare journey.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the absolute clinical accuracy of the Anti Tissue Transglutaminase IgA test at Ayzal Lab, patients must adhere to specific pre-analytical preparation guidelines. Because this test measures the immune system’s active response to gluten, the patient must maintain a normal, gluten-containing diet for at least six to eight weeks prior to sample collection. Prematurely eliminating gluten from the diet can cause antibody levels to drop significantly, potentially leading to a false-negative result that delays proper diagnosis and treatment.

  • Maintain a Gluten-Inclusive Diet: Consume foods containing wheat, barley, or rye (such as bread, pasta, and cereals) daily in the weeks leading up to the test.
  • Fasting Requirements: Routine fasting is generally not mandatory for the tTG-IgA test; however, patients are advised to follow any specific instructions provided by their referring physician or the Ayzal Lab staff.
  • Medication Review: Inform the laboratory staff and your doctor about any immunosuppressive medications or systemic corticosteroids you are currently taking, as these can suppress antibody production and alter test outcomes.
  • Hydration: Ensure adequate hydration before the blood draw, as this makes the veins more accessible and facilitates a smoother venipuncture process.

During the Procedure

The Anti Tissue Transglutaminase IgA test is a standard venipuncture procedure performed by the highly trained phlebotomists at Ayzal Lab. The entire sample collection process is designed with patient comfort, safety, and strict hygiene protocols in mind, typically taking less than five to ten minutes from start to finish.

  • Patient Positioning: The patient is comfortably seated in a specialized phlebotomy chair, and the arm is positioned on a supportive armrest.
  • Site Selection and Sanitization: The phlebotomist examines the antecubital fossa (the inner elbow area) to locate a suitable vein. Once selected, the skin is thoroughly cleansed with an antiseptic swab to prevent contamination.
  • Tourniquet Application: A sterile elastic band is applied to the upper arm to temporarily restrict venous blood flow, making the target vein more prominent and easier to access.
  • Sample Collection: A sterile, single-use needle is gently inserted into the vein. A vacuum collection tube (typically a gold-top serum separator tube or red-top tube) is attached to collect the required volume of blood.
  • Needle Removal and Hemostasis: Once the tube is filled, the tourniquet is released, the needle is carefully withdrawn, and immediate pressure is applied to the puncture site with a sterile cotton ball or gauze pad to stop any localized bleeding.
  • Dressing and Post-Care: A small adhesive bandage is applied over the site. Patients are advised to keep the bandage on for a few hours and avoid heavy lifting with that arm for the remainder of the day.

When is an Anti Tissue Transglutaminase IgA (TTG) Test Performed?

Screening for Celiac Disease

Physicians routinely request the tTG-IgA test when a patient presents with classic gastrointestinal symptoms suggestive of celiac disease. These symptoms include chronic diarrhea, persistent abdominal pain, bloating, flatulence, unexplained weight loss, and steatorrhea (fatty, foul-smelling stools). The test helps clinicians differentiate celiac disease from irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), or food intolerances, allowing for the initiation of an appropriate, targeted treatment plan.

Investigating Unexplained Nutritional Deficiencies

When the small intestinal villi are damaged by celiac disease, the body’s ability to absorb essential nutrients is severely compromised. Clinicians order this test for patients presenting with unexplained iron-deficiency anemia that does not respond to oral iron supplementation, vitamin D deficiency, osteopenia, osteoporosis, or unexplained weight loss. Identifying the underlying autoimmune enteropathy is crucial to reversing these deficiencies and preventing long-term skeletal and systemic complications.

Evaluating Pediatric Growth and Development Issues

In infants and children, celiac disease can manifest as a failure to thrive, delayed puberty, short stature, chronic constipation, vomiting, and irritability. Pediatricians utilize the tTG-IgA test at Ayzal Lab to screen children showing these developmental delays. Early detection and dietary intervention are vital in pediatric cases to ensure normal physical growth, bone mineralization, and cognitive development.

Monitoring Adherence to a Gluten-Free Diet

For patients already diagnosed with celiac disease, the tTG-IgA test serves as an effective monitoring tool. After initiating a strict gluten-free diet, antibody levels should gradually decline and eventually return to the normal range, typically within six to twelve months. Periodic testing helps gastroenterologists assess dietary compliance, identify accidental gluten exposure, and evaluate the healing progress of the intestinal mucosa.

Screening High-Risk and Asymptomatic Individuals

Because celiac disease has a strong genetic component, screening is highly recommended for asymptomatic individuals who have first-degree relatives (parents, siblings, or children) diagnosed with the condition. Additionally, patients with other autoimmune disorders, such as Type 1 diabetes mellitus, autoimmune thyroiditis, rheumatoid arthritis, or genetic conditions like Down syndrome and Turner syndrome, are at a significantly higher risk and should undergo routine tTG-IgA screening.

What Does an Anti Tissue Transglutaminase IgA (TTG) Test Detect?

The Anti Tissue Transglutaminase IgA test measures the concentration of specific autoantibodies in the blood. The findings from this test can indicate several clinical states:

  • Absence of Celiac-Specific Autoantibodies: A normal or negative result suggests that celiac disease is highly unlikely, provided the patient was consuming a normal gluten-containing diet at the time of testing.
  • Active Autoimmune Response to Gluten: Elevated levels of tTG-IgA indicate an active immune reaction against the tissue transglutaminase enzyme, strongly pointing to celiac disease or dermatitis herpetiformis.
  • Dietary Compliance: In diagnosed celiac patients, a decreasing or undetectable antibody level confirms successful adherence to a gluten-free diet.
  • Accidental Gluten Exposure: Persistently high or rising antibody levels in patients on a gluten-free diet suggest ongoing, possibly inadvertent, ingestion of gluten.
  • Potential IgA Deficiency: A very low or undetectable level of total IgA along with a negative tTG-IgA can indicate selective IgA deficiency, a condition relatively common in celiac patients that can cause false-negative tTG-IgA results.
  • Dermatitis Herpetiformis: This severe, blistering skin rash is the cutaneous manifestation of celiac disease and is strongly associated with elevated tTG-IgA levels.
  • Small Intestinal Mucosal Damage: High antibody titers correlate closely with the severity of villous atrophy in the duodenum.
  • Autoimmune Enteropathy: The test helps identify autoimmune-mediated damage to the digestive tract.
  • Refractory Celiac Disease: Persistently elevated levels despite strict dietary adherence may raise suspicion for refractory celiac disease, requiring further specialized gastroenterological evaluation.

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand that waiting for diagnostic results can be a source of anxiety for patients and their families. We are committed to providing rapid, accurate, and reliable reporting. The turnaround time for the Anti Tissue Transglutaminase IgA test is typically within 24 to 48 hours from the time of sample collection. Once the analysis is complete, the report undergoes a rigorous multi-level verification process by our qualified laboratory professionals to ensure absolute accuracy. Patients can easily access their reports online through the official Ayzal Lab web portal or receive them directly via WhatsApp and email, eliminating the need for unnecessary travel back to the collection center.

Anti Tissue Transglutaminase IgA (TTG) Findings Overview

The following table outlines the typical clinical parameters evaluated during the tTG-IgA test, along with normal and potential abnormal findings:

Structure / Parameter Evaluated Normal Findings Possible Abnormal Findings
tTG-IgA Antibody Level < 10 U/mL (Negative) ≥ 10 U/mL (Positive – suggestive of active celiac disease or dermatitis herpetiformis)
Total Serum IgA Within age-specific reference range Below normal range (indicates selective IgA deficiency, requiring tTG-IgG testing)
Intestinal Mucosal Correlation Intact villi, normal absorption capacity Villous atrophy, crypt hyperplasia, and malabsorption (associated with high tTG-IgA)
Gluten-Free Diet Response Antibody levels decrease to normal range Persistently elevated levels (indicates ongoing gluten exposure or refractory disease)
Clinical Symptoms Correlation No gluten-induced gastrointestinal distress Chronic diarrhea, bloating, abdominal pain, and nutritional deficiencies
Pediatric Growth Parameters Normal growth and developmental milestones Failure to thrive, short stature, and delayed puberty in children
Skeletal Health Indicators Normal bone density and calcium absorption Osteopenia or osteoporosis secondary to chronic malabsorption

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for Anti Tissue Transglutaminase IgA (TTG)?

  • Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists and technologists dedicated to diagnostic excellence.
  • Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the testing process.
  • Quality Diagnostic Services: Ayzal Lab utilizes advanced automated analyzers to deliver highly precise and reproducible results.
  • Professional Reporting: Our reports are comprehensive, easy to understand, and verified by senior laboratory specialists.
  • Modern Diagnostic Approach: We employ state-of-the-art laboratory methodologies in line with international diagnostic standards.
  • Comfortable Environment: Our collection centers are designed to provide a clean, hygienic, and stress-free experience for all patients.
  • Convenient Location: Easily accessible facilities in Lahore ensure hassle-free visits for routine and specialized testing.
  • Commitment to Accurate Diagnosis: We maintain strict internal and external quality control protocols to ensure the highest level of diagnostic accuracy.

Frequently Asked Questions